We used Western blotting to screen an in-house library of natural compounds to identify those that could potentially alter ZEB1 protein stability (Supplementary Table S1) through their influence on ZEB1 expression in MDA-MB-231 breast cancer cells. This evidence concerns the gene ZEB1 and breast carcinoma.